Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sightnovo Medical, often branded as SinoVision, is a leading Chinese medical imaging company specializing in the development and manufacture of advanced Computed Tomography (CT) systems. Founded in 2012 and headquartered in Beijing, the company offers a comprehensive portfolio of diagnostic imaging solutions, including the Insitum CT series ranging from 16 to 128 slices. Beyond hardware, Sightnovo integrates artificial intelligence and cloud-based platforms to enhance diagnostic accuracy and workflow efficiency for healthcare providers. The company also develops interventional robotic systems designed to assist in precision procedures. With a strong focus on both domestic and international markets, Sightnovo aims to deliver high-quality, accessible medical technology globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Sightnovo Medical Technology.